Environmental risk assessment of medicinal products for human use according to European Commission recommendations
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Presented here, based on new recommendations of the European Commission, is an environmental risk assessment (ERA) of a selected group of pharmaceuticals for Phase I, environmental exposure assessment, and Phase II Tier A, initial environmental fate and effect analysis. This pharmaceutical group is composed of the 111 highest‐selling human drug substances that have annual sales in Germany of more than 5,000 kg. The data required for this ERA came from analyzing: (1) sales annually (in kg or IU) of the 2671 active pharmaceutical drug substances (2001) on the German market in all medicinal products sold by pharmacies (with and without prescriptions) and used in hospitals in 1996–2001; (2) the use pattern of drug substances as categorized according to Anatomical Therapeutic Chemical (ATC) classification indexes ATC3 and ATC7; (3) data for excretion, toxicity, and metabolites of the 111 selected human drug substances; (4) the physicochemical properties of these substances; and (5) the degradability of selected drug substances in sewage treatment plants (STPs) by using a validated and accredited liquid chromatography–electrospray ionization tandem mass spectrometry method. A correction factor for the pharmaceutical therapeutic (PT) activity of metabolites, the PT Index (excretion rate/100) for drug substances and PT active metabolites was established to refine the predicted environmental concentration (PEC SURFACEWATER). A refinement of the PEC SURFACEWATER was carried out with the market penetration factor of the human drug substances in Germany. In addition, for effect analysis the predicted no‐effects concentration (PNEC) was calculated using assessment factors. The estimated PEC results were validated with the exposure results of effluents of the STPs. All results on ERA of drug substances have been documented in a Microsoft Access 2000 database. © 2004 Wiley Periodicals, Inc. Environ Toxicol 19: 226–240, 2004.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Occurrence of Antibiotics in the Aquatic Environment
Hirsch, R., Ternes, T., Haberer, K., & Kratz, K.-L. (1999) · Science of The Total Environment · doi:10.1016/s0048-9697(98)00337-4 · Cited by 2,140
Cited by
Luo, Y., Guo, W., Ngo, H. H., Nghiem, L. D., Hai, F. I., Zhang, J., Liang, S., & Wang, X. C. (2014) · Science of The Total Environment · doi:10.1016/j.scitotenv.2013.12.065 · Cited by 3,983
Ecotoxicology of human pharmaceuticals
Fent, K., Weston, A. A., & Caminada, D. (2006) · Aquatic Toxicology · doi:10.1016/j.aquatox.2005.09.009 · Cited by 3,223
Patel, M., Kumar, R., Kishor, K., Mlsna, T., Pittman, C. U., & Mohan, D. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00299 · Cited by 2,654
Emerging organic contaminants in groundwater: A review of sources, fate and occurrence
Lapworth, D. J., Baran, N., Stuart, M. E., & Ward, R. S. (2012) · Environmental Pollution · doi:10.1016/j.envpol.2011.12.034 · Cited by 1,895
HERNANDO, M., MEZCUA, M., FERNANDEZALBA, A., & BARCELO, D. (2006) · Talanta · doi:10.1016/j.talanta.2005.09.037 · Cited by 1,730
Metadata
- Authors
- Huschek, G., Hansen, P. D., Maurer, H. H., Krengel, D., & Kayser, A.
- Venue
- Environmental Toxicology
- Publisher
- Wiley
- Published
- 2004-04-15
- Volume
- 19
- Issue
- 3
- Pages
- 226-240
- ISSN
- 1520-4081 (ISSN-L)
- 1522-7278
- OpenAlex
- W2031237671
- Cited by
- 149
- References
- 1
- FWCI
- 5.29
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Environmental risk assessment of medicinal products for human use according to European Commission recommendations. https://app.cochat.ai/papers/10.1002/tox.20015
- The paper
- Huschek, G., Hansen, P. D., Maurer, H. H., Krengel, D., & Kayser, A. (2004). Environmental risk assessment of medicinal products for human use according to European Commission recommendations. Environmental Toxicology. https://doi.org/10.1002/tox.20015
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.